[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Mimedx Group Inc (MDXG)

Mimedx Group Inc (MDXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 509,585
  • Shares Outstanding, K 148,567
  • Annual Sales, $ 418,630 K
  • Annual Income, $ 48,580 K
  • EBIT $ 64 M
  • EBITDA $ 79 M
  • 60-Month Beta 1.65
  • Price/Sales 1.19
  • Price/Cash Flow 5.97
  • Price/Book 1.91

Options Overview Details

View History
  • Implied Volatility 125.74% (-20.15%)
  • Historical Volatility 47.71%
  • IV Percentile 47%
  • IV Rank 15.56%
  • IV High 683.97% on 03/04/26
  • IV Low 22.85% on 09/04/25
  • Expected Move (DTE 20) 0.98 (28.50%)
  • Put/Call Vol Ratio 0.06
  • Today's Volume 147
  • Volume Avg (30-Day) 72
  • Put/Call OI Ratio 0.90
  • Today's Open Interest 3,675
  • Open Int (30-Day) 3,234
  • Expected Range 2.45 to 4.41

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.07
  • Number of Estimates 1
  • High Estimate $-0.07
  • Low Estimate $-0.07
  • Prior Year $0.06
  • Growth Rate Est. (year over year) -216.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.18 +7.69%
on 04/21/26
4.22 -18.62%
on 03/25/26
-0.70 (-16.95%)
since 03/24/26
3-Month
3.18 +7.69%
on 04/21/26
5.46 -37.18%
on 02/24/26
-1.83 (-34.79%)
since 01/23/26
52-Week
3.18 +7.69%
on 04/21/26
7.99 -57.07%
on 07/31/25
-3.37 (-49.56%)
since 04/24/25

Most Recent Stories

More News
MIMEDX to Host First Quarter 2026 Operating and Financial Results Conference Call on April 29

MARIETTA, Ga., April 22, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the...

MDXG : 3.43 (+2.39%)
MIMEDX Announces Restructuring and Cost Reduction Initiative

MARIETTA, Ga., April 16, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced a series of cost reduction initiatives intended to prioritize growth...

MDXG : 3.43 (+2.39%)
MIMEDX to Sponsor Leading Advanced Wound Care Conferences

Multispecialty Focus with Industry Leadership Aimed at Improving Patient Outcomes Company Will Feature Recent Additions to Its Advanced Wound Care Portfolio MARIETTA, Ga., April 02, 2026 (GLOBE...

MDXG : 3.43 (+2.39%)
MIMEDX Announces Launch of CHORIOFIX™

MARIETTA, Ga., March 23, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the commercial launch of CHORIOFIX™, the latest advanced wound...

MDXG : 3.43 (+2.39%)
MIMEDX Expands Surgical Product Portfolio with the Launch of AMNIOFIX® Thyroid Shields

MARIETTA, Ga., March 05, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the commercial launch of AMNIOFIX Thyroid Shields, a product line...

MDXG : 3.43 (+2.39%)
MiMedx: Q4 Earnings Snapshot

MiMedx: Q4 Earnings Snapshot

MDXG : 3.43 (+2.39%)
MIMEDX Announces Record Fourth Quarter and Full Year 2025 Operating and Financial Results

Net Sales Grew 27% Year-Over-Year for the Fourth Quarter and 20% for the Full Year Fourth Quarter GAAP Net Income and Earnings Per Share were $15 million and $0.10 , Respectively Fourth...

MDXG : 3.43 (+2.39%)
MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25

MARIETTA, Ga., Feb. 17, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the...

MDXG : 3.43 (+2.39%)
MIMEDX Enters into Exclusive Distribution Agreement with Summit Products Group for Multiple Innovative Surgical & Wound Products

MARIETTA, Ga., Feb. 04, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced it has entered into an exclusive agreement with Summit Products...

MDXG : 3.43 (+2.39%)
MIMEDX Celebrates 15 Year Anniversary of EPIFIX® and AMNIOFIX®

MARIETTA, Ga., Feb. 02, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the 15 th anniversary of EPIFIX and AMNIOFIX, the Company’s placental...

MDXG : 3.43 (+2.39%)

Business Summary

MiMedx is an integrated developer, processor and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. `Innovations in Regenerative Biomaterials` is the framework behind their mission to give physicians products and tissues to help the...

See More

Key Turning Points

3rd Resistance Point 3.73
2nd Resistance Point 3.62
1st Resistance Point 3.52
Last Price 3.43
1st Support Level 3.31
2nd Support Level 3.20
3rd Support Level 3.10

See More

52-Week High 7.99
Fibonacci 61.8% 6.15
Fibonacci 50% 5.59
Fibonacci 38.2% 5.02
Last Price 3.43
52-Week Low 3.18

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.